Royal Bank of Canada
CANC icon

Royal Bank of Canada’s Tema Oncology ETF CANC Stock Holding History

Royal Bank of Canada’s Portfolio CANC Stock Details CANC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-121
Closed -$3K – 6911
2024
Q3 		$3K Buy
+121
New +$3.48K ﹤0.01% 6583

Other funds holding CANC

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada's CANC Position: Q4 2024 in Review

Royal Bank of Canada sold out of Tema Oncology ETF (CANC) in Q4 2024, closing a stake of 121 shares — an estimated $3K sold.

Royal Bank of Canada first reported a position in CANC in Q3 2024 and held it in 1 quarter. The position peaked at $3K in Q3 2024. 3 funds tracked by Wall St. Rank hold CANC as of Q4 2024.

  • Royal Bank of Canada reported no remaining Tema Oncology ETF position as of Q4 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 121 Tema Oncology ETF shares in Q4 2024, an estimated $3K.
  • Royal Bank of Canada first reported a position in Tema Oncology ETF in Q3 2024 and held it in 1 quarter.
  • Royal Bank of Canada's Tema Oncology ETF position peaked at $3K in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q4 2024.

Based on Royal Bank of Canada's 13F filing for Q4 2024, filed 14 Feb 2025.